Skip to main content

Actuate Therapeutics

Founded: 2015

Northwestern Inventor:
Andrew Mazar
Weinberg School of Arts and Sciences
Chemistry of Life Processes

Actuate Therapeutics, Inc. is a private biopharmaceutical company developing novel therapeutics that target Glycogen Synthase Kinase-3β (GSK-3β). Activity and overexpression of GSK-3β have been implicated in many conditions, including Alzheimer’s disease, bipolar disorder, diabetes mellitus type II, inflammatory conditions, and cancer.

Actuate Therapeutics Website